• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Pharmaceutical Market
    Pharmaceutical News
    Pharmaceutical Stocks
    • Pharmaceutical Market
    • Pharmaceutical News
    • Pharmaceutical Stocks
    pharmaceutical investing

    Ascendis Pharma Announces Proposed Public Offering of ADSs

    Gabrielle Lakusta
    Feb. 20, 2018 03:05PM PST
    Pharmaceutical Investing

    Ascendis Pharma (Nasdaq:ASND), a clinical stage biopharmaceutical company, announced that it has commenced an underwritten public offering of $150,000,000 of American Depositary Shares, each of which represents one ordinary share of Ascendis. As quoted in the press release:  The offering is subject to market and other conditions, and there can be no assurance as to whether or …

    Ascendis Pharma (Nasdaq:ASND), a clinical stage biopharmaceutical company, announced that it has commenced an underwritten public offering of $150,000,000 of American Depositary Shares, each of which represents one ordinary share of Ascendis.

    As quoted in the press release:

     The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. J.P. Morgan Securities LLC, BofA Merrill Lynch and Credit Suisse Securities (USA) LLC are acting as joint book-running managers for the offering.

    Click here to read the full press release.

    j.p. morganpharmaceutical investingunderwritten public offeringmerrill lynchpublic offeringclinical-stage biopharmaceuticalamerican depositary sharesclinical-stage biopharmaceutical companycredit suisse
    The Conversation (0)

    Go Deeper

    AI Powered
    Row of test tubes and pipette with chemical droplet chemical coming from it.

    Top 5 Small-cap Biotech Stocks of 2025

    Medicine capsule showing active ingredients.

    5 Biggest Pharma Stocks

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Pharmaceutical Investing Stocks

    Invion Limited

    IVX:AU

    Cardiol Therapeutics

    CRDL:CA
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×